1	Transactivation	Transactivation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
6	virus	virus	_	_	_	_	_	_	_
7	promoter	promoter	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	herpesvirus	herpesvirus	_	_	_	_	_	_	_
11	6	6	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	HHV-6	hhv-6	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	strains	strain	_	_	_	_	_	_	_
16	GS	gs	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	Z-29	z-29	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	primary	primary	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	T	t	_	_	_	_	_	_	_
23	lymphocytes	lymphocyte	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	identification	identification	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	transactivating	transactivate	_	_	_	_	_	_	_
28	HHV-6(GS)	hhv-6(gs)	_	_	_	_	_	_	_
29	gene	gene	_	_	_	_	_	_	_
30	fragments	fragment	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	herpesvirus	herpesvirus	_	_	_	_	_	_	_
3	6	6	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	HHV-6	hhv-6	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	can	can	_	_	_	_	_	_	_
8	activate	activate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
12	virus	virus	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	HIV	HIV	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	promoter	promoter	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	accelerate	accelerate	_	_	_	_	_	_	_
19	cytopathic	cytopathic	_	_	_	_	_	_	_
20	effects	effect	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	HIV-infected	hiv-infected	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	T	t	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	examines	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	regions	region	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	HIV	HIV	_	_	_	_	_	_	_
9	promoter	promoter	_	_	_	_	_	_	_
10	required	require	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	HHV-6	HHV-6	_	_	_	_	_	_	_
13	transactivation	transactivation	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	heterogeneous	heterogeneous	_	_	_	_	_	_	_
17	population	population	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	primary	primary	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	lymphocytes	lymphocyte	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	or	or	_	_	_	_	_	_	_
25	without	without	_	_	_	_	_	_	_
26	antigenic	antigenic	_	_	_	_	_	_	_
27	stimulation	stimulation	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Two	two	_	_	_	_	_	_	_
2	different	different	_	_	_	_	_	_	_
3	strains	strain	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	HHV-6	HHV-6	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	GS	GS	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	Z29	Z29	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	transactivated	transactivate	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	HIV	HIV	_	_	_	_	_	_	_
14	promoter	promoter	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	GS	gs	_	_	_	_	_	_	_
3	strain	strain	_	_	_	_	_	_	_
4	transactivated	transactivate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	both	both	_	_	_	_	_	_	_
9	stimulated	stimulate	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	resting	rest	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	while	while	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	Z29	z29	_	_	_	_	_	_	_
18	strain	strain	_	_	_	_	_	_	_
19	increased	increase	_	_	_	_	_	_	_
20	HIV	HIV	_	_	_	_	_	_	_
21	promoter	promoter	_	_	_	_	_	_	_
22	activity	activity	_	_	_	_	_	_	_
23	only	only	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	stimulated	stimulate	_	_	_	_	_	_	_
26	T	t	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Three	three	_	_	_	_	_	_	_
2	DNA	DNA	_	_	_	_	_	_	_
3	clones	clone	_	_	_	_	_	_	_
4	containing	contain	_	_	_	_	_	_	_
5	HHV-6(GS)	hhv-6(gs)	_	_	_	_	_	_	_
6	genomic	genomic	_	_	_	_	_	_	_
7	fragments	fragment	_	_	_	_	_	_	_
8	transactivated	transactivate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	HIV	HIV	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	cotransfected	cotransfecte	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	21.4-kb	21.4-kb	_	_	_	_	_	_	_
3	DNA	dna	_	_	_	_	_	_	_
4	clone	clone	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	pZVB70	pzvb70	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	showed	show	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	highest	high	_	_	_	_	_	_	_
11	transactivating	transactivating	_	_	_	_	_	_	_
12	ability	ability	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	while	while	_	_	_	_	_	_	_
15	two	two	_	_	_	_	_	_	_
16	other	other	_	_	_	_	_	_	_
17	DNA	dna	_	_	_	_	_	_	_
18	fragments	fragment	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	pZVB10	pzvb10	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	6.2	6.2	_	_	_	_	_	_	_
23	kb	kb	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	pZVH14	pzvh14	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	8.7	8.7	_	_	_	_	_	_	_
29	kb	kb	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	showed	show	_	_	_	_	_	_	_
33	lower	low	_	_	_	_	_	_	_
34	activity	activity	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	clones	clone	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	pZVH14	pzvh14	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	activated	activate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	HIV	HIV	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	construct	construct	_	_	_	_	_	_	_
13	containing	contain	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	mutation	mutation	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	NF	NF	_	_	_	_	_	_	_
19	kappa	kappa	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	site	site	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	mutated	mutate	_	_	_	_	_	_	_
5	NF	NF	_	_	_	_	_	_	_
6	kappa	kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	promoter	promoter	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	transactivated	transactivate	_	_	_	_	_	_	_
12	during	during	_	_	_	_	_	_	_
13	HHV-6(GS)	hhv-6(gs)	_	_	_	_	_	_	_
14	infection	infection	_	_	_	_	_	_	_
15	or	or	_	_	_	_	_	_	_
16	after	after	_	_	_	_	_	_	_
17	cotransfection	cotransfection	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	pZVB70	pzvb70	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	pZVB10	pzvb10	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	NF	NF	_	_	_	_	_	_	_
7	kappa	kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	sites	site	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	HIV	HIV	_	_	_	_	_	_	_
13	promoter	promoter	_	_	_	_	_	_	_
14	are	be	_	_	_	_	_	_	_
15	essential	essential	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	its	its	_	_	_	_	_	_	_
18	transactivation	transactivation	_	_	_	_	_	_	_
19	during	during	_	_	_	_	_	_	_
20	HHV-6(GS)	hhv-6(gs)	_	_	_	_	_	_	_
21	infection	infection	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	increasing	increase	_	_	_	_	_	_	_
3	HIV	HIV	_	_	_	_	_	_	_
4	promoter	promoter	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	primary	primary	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	lymphocytes	lymphocyte	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	HHV-6	HHV-6	_	_	_	_	_	_	_
12	may	may	_	_	_	_	_	_	_
13	consequently	consequently	_	_	_	_	_	_	_
14	increase	increase	_	_	_	_	_	_	_
15	HIV	HIV	_	_	_	_	_	_	_
16	replication	replication	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	leading	lead	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	an	an	_	_	_	_	_	_	_
21	increase	increase	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	cytopathic	cytopathic	_	_	_	_	_	_	_
25	effect	effect	_	_	_	_	_	_	_
26	on	on	_	_	_	_	_	_	_
27	coinfected	coinfecte	_	_	_	_	_	_	_
28	human	human	_	_	_	_	_	_	_
29	T	t	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

